The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease

Autor: Vodegel, R. M., Kiss, M., Jong, M. C. J. M., Hendri Pas, Altmayer, A., Molnar, K., Husz, S., Meer, J. B., Jonkman, M. F.

Publikováno v: Scopus-Elsevier
European journal of dermatology, 8(2), 83-85. JOHN LIBBEY EUROTEXT

A case is presented of subepidermal, autoimmune bullous disease in which the initial examinations suggested the combination of epidermolysis bullosa acquisita and bullous pemphigoid. The diagnosis of epidermolysis bullosa acquisita was made by indire

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::59047254ef61dcdd2bf36329ed49f890
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031920824&partnerID=MN8TOARS

U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.

Autor: Vodegel RM; Center for Blistering Diseases, Department of Dermatology, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands., Jonkman MF, Pas HH, de Jong MC

Publikováno v: The British journal of dermatology [Br J Dermatol] 2004 Jul; Vol. 151 (1), pp. 112-8.

Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser.

Autor: Njoo MD; Netherlands Institute for Pigmentary Disorders, Amsterdam., Vodegel RM, Westerhof W

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2000 May; Vol. 42 (5 Pt 1), pp. 760-9.

Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement.

Autor: Venneker GT; Department of Dermatology, Academisch Medisch Centrum, University of Amsterdam, The Netherlands., Vodegel RM, Okada N, Westerhof W, Bos JD, Asghar SS

Publikováno v: Immunobiology [Immunobiology] 1998 Feb; Vol. 198 (4), pp. 476-84.